ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,050.00
-106.00 (-0.87%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -106.00 -0.87% 12,050.00 12,036.00 12,038.00 12,178.00 12,010.00 12,092.00 1,635,146 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.34 186.61B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,156p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,266.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.61 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.34.

Astrazeneca Share Discussion Threads

Showing 2826 to 2846 of 6150 messages
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
26/7/2020
10:45
Alternatively you could just post a valid URL
adobbing
26/7/2020
10:38
hxxps://www-fool-com.cdn.ampproject.org/v/s/www.fool.com/amp/investing/2020/07/25/3-top-pharma-stocks-to-buy-right-now.aspx?amp_js_v=a3&amp_gsa=1&usqp=mq331AQIKAGwASDYAQE%3D#referrer=hxxps%3A%2F%2Fwww.google.com&amp_tf=From%20%251%24s&ampshare=hxxps%3A%2F%2Fwww.fool.com%2Finvesting%2F2020%2F07%2F25%2F3-top-pharma-stocks-to-buy-right-now.aspx
beckers2008
25/7/2020
11:34
Well I sold half at 91.50 but may buy back if it gos much lower. Course it would have been better if I could have sold at 96 but it doesn't pay to be too greedy
mercury123
24/7/2020
17:25
bunz3, do you not have access to trades?

Buy v sell 968k/616k. Nought to do with selling.

Go figure.

dudishes
24/7/2020
08:19
DON T KNOW WHY SO MUCH SELLING
NOT MAKING SENCE IN MY VIEW ,HAD HOPED FOR MORE OF A MOVE UP NOT ALL THIS SELLING
HOPING MANY OF SELLERS NOW MIGHT BE CLEARED

bunz3
23/7/2020
16:06
surely AZN will get support at 8600 level !
arja
21/7/2020
21:43
Hi all,

My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion covers AZN. We also chatted about loads of other Stocks and as always a fair bit of general Portfolio Management educational stuff. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 27) and you can find it on Soundcloud at the link below.

I hope you enjoy it and find it useful,

Cheers, WD
@wheeliedealer

thewheeliedealer
21/7/2020
08:50
zaxarobai .
every 3 months ? are you joking ?

arja
20/7/2020
16:20
It takes years to prove safety.
Testing these young fit people is a start.

But it is only a start.
Covid19 does not bother them too much.

Side effects of a powerful vaccine such as this could be worse than the original virus.
Long term effects.

Stay patient. It sounds like a good start.

careful
20/7/2020
16:11
Think how much AZN can make off a vaccine that we all have to get every three months.
zaxarobal
20/7/2020
16:03
If there is positive news on the vaccine , I'm expecting the share price to double within 6 months
squintyflinty1
20/7/2020
15:11
Usual buy rumour sell on news nonsense
sundance 13
20/7/2020
15:10
It seems to be exactly what was leaked last week.
smcni1968
20/7/2020
15:07
May be the market expected data from the 5000 in Brazil who have been on the trial for the last month.If they had said that, say, 20 on the placebo got covid but none on the vaccine have got it, that would be massive news.
paa65
20/7/2020
14:53
In conclusion, ChAdOx1 nCoV-19 was safe, tolerated, and immunogenic, while reactogenicity was reduced with paracetamol. A single dose elicited both humoral and cellular responses against SARS-CoV-2, with a booster immunisation augmenting neutralising anti- body titres. The preliminary results of this first-in-human clinical trial supported clinical development progression into ongoing phase 2 and 3 trials. Older age groups with comorbidities, health-care workers, and those with higher risk for SARS-CoV-2 exposure are being recruited and assessed for efficacy, safety, and immunogenicity of ChAdOx1 nCoV-19 given as a single-dose or two-dose administration regimen in further trials conducted in the UK and overseas. We will also evaluate the vaccine in children, once sufficient safety data have been accumu- lated in adult studies. Phase 3 trials are now underway in Brazil, South Africa, and the UK and will evaluate vaccine efficacy in diverse populations.
filament
20/7/2020
14:51
was it so bad or maybe not as good as expected !
arja
20/7/2020
14:41
Report released
smcni1968
20/7/2020
14:31
For interest
mirandaj
20/7/2020
14:18
Happy with 5% rise whilst we await news. Not very often such a blue chip has that size of daily rise
ayl30
20/7/2020
13:42
The authors have no control over the publication date or time.
relwood
20/7/2020
13:38
A bit dramatic.
the whole world waits for this data.

How the scientists love the limelight.
we discovered that during the pandemic.

careful
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older

Your Recent History

Delayed Upgrade Clock